Have We Lost the Cannabis Legalization War?

Listen to Dr. Kevin Sabet’s discussion on High Truths on
Drugs and Addiction, Episode #23

Have we lost the cannabis legalization war? This is a question posed to Dr. Kevin Sabet, IASIC Advisor, former White House Advisor, and president and CEO of SAM, Smart Approaches to Marijuana. Listen to his expertise on High Truths on Drugs and Addiction, Episode #23.

Is there even a war on drugs anymore? How can people in prevention go against a billion-dollar marijuana goliath industry? Dr. Sabet has a thoughtful conversation with Dr. Roneet Lev on High Truths.

Listen Now

About Kevin Sabet, PhD
An affiliate of the Institution for Social and Policy Studies and the Medical School at Yale University, and dubbed by NBC News as the “prodigy of drug politics,” author, consultant, and advisor to three U.S. presidential administrations, Kevin A. Sabet, Ph.D., has studied, researched, written about, and implemented drug policy for 25 years. He is currently the President and CEO of SAM (Smart Approaches to Marijuana), a non-profit organization he founded with Congressman Patrick Kennedy and David Frum. His latest book, Smokescreen: What the Marijuana Industry Doesn’t Want You to Know, is distributed by Simon & Schuster. He is the only person appointed by Republicans and Democrats to work at the White House drug office, and he is a columnist for Newsweek. He received his doctorate from Oxford University.

Listen to Episode #23 Now

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org. 

Visit the IASIC Library here. The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top